Supernus Pharmaceuticals
SUPN
#4047
Rank
C$4.05 B
Marketcap
C$70.39
Share price
-1.87%
Change (1 day)
53.86%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of December 2025 : C$2.02 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are C$2.02 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2025-12-31C$1.98 B1.33%
2024-12-31C$1.96 B15.84%
2023-12-31C$1.69 B-26.65%
2022-12-31C$2.31 B7.32%
2021-12-31C$2.15 B12.25%
2020-12-31C$1.91 B26.56%
2019-12-31C$1.51 B13.77%
2018-12-31C$1.33 B149.59%
2017-12-31C$0.53 B28.28%
2016-12-31C$0.41 B58.99%
2015-12-31C$0.26 B64.84%
2014-12-31C$0.15 B34.35%
2013-12-31C$0.11 B26.42%
2012-12-31C$93.46 M71.01%
2011-12-31C$54.65 M16.31%
2010-12-31C$46.99 M-44.11%
2009-12-31C$84.06 M-10.36%
2008-12-31C$93.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$277.77 B 13,613.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$120.91 B 5,869.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$156.83 B 7,642.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$125.54 B 6,098.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
C$10.98 B 442.46%๐Ÿ‡บ๐Ÿ‡ธ USA